PIRAMAL PHARMA
Back to Cashflow Statement
|
PIRAMAL PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹788 Cr | ₹-26 Cr | ₹148 Cr | ₹-37 Cr | ₹-251 Cr |
What is the latest Net Cash Inflow / Outflow ratio of PIRAMAL PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹788 Cr |
| Mar2025 | ₹-26 Cr |
| Mar2024 | ₹148 Cr |
| Mar2023 | ₹-37 Cr |
| Mar2022 | ₹-251 Cr |
How is Net Cash Inflow / Outflow of PIRAMAL PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹788 Cr | Positive | |
| Mar2025 | ₹-26 Cr | Negative | |
| Mar2024 | ₹148 Cr | Positive | |
| Mar2023 | ₹-37 Cr | Negative | |
| Mar2022 | ₹-251 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹27,897.4 Cr | -1.4% | 13.4% | 11.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,394.0 Cr | -2.3% | -3.3% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,312.0 Cr | 0.3% | 16.3% | 44.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,678.0 Cr | 2.8% | -0.5% | 37.1% | Stock Analytics | |
| CIPLA | ₹114,392.0 Cr | -3.1% | -1.2% | -5.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,740.5 Cr | -2.9% | -3% | -3.3% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -1.4% |
13.4% |
11.2% |
| SENSEX | -1.4% |
-1% |
-4.6% |
You may also like the below Video Courses